Cargando…

Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? – A Case Report

PURPOSE: Pharmacogenetic (PGx) panel testing could help to determine the heritable component of a rheumatoid arthritis (RA) patient’s susceptibility for therapy failure and/or adverse drug reactions (ADRs) from methotrexate (MTX). Considering the literature mentioning the potential applicability of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeiziner, Chiara, Allemann, Samuel S, Hersberger, Kurt E, Meyer zu Schwabedissen, Henriette E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109898/ https://www.ncbi.nlm.nih.gov/pubmed/35586477 http://dx.doi.org/10.2147/PGPM.S354011

Ejemplares similares

Pharmacogenetic testing and counselling in the community pharmacy: mixed-methods study of a new pharmacist-led service
por: Jeiziner, Chiara, et al.
Publicado: (2023)

Pharmacogenetics in Pharmaceutical Care—Piloting an Application-Oriented Blended Learning Concept
por: Stäuble, Céline K., et al.
Publicado: (2021)

Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series Study
por: Bollinger, Anna, et al.
Publicado: (2023)

Enriching Medication Review with a Pharmacogenetic Profile – A Case of Tamoxifen Adverse Drug Reactions
por: Jeiziner, Chiara, et al.
Publicado: (2021)

A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare Setting
por: Stäuble, Céline K., et al.
Publicado: (2022)

Pharmacist-guided pre-emptive pharmacogenetic testing in antidepressant therapy (PrePGx): study protocol for an open-label, randomized controlled trial
por: Stäuble, Céline K., et al.
Publicado: (2021)

HLA‐associated adverse drug reactions ‐ scoping review
por: Jeiziner, Chiara, et al.
Publicado: (2021)

Utilization of Drugs with Pharmacogenetic Dosing Recommendations in Switzerland: A Descriptive Study Using the Helsana Database
por: Wittwer, Nina L, et al.
Publicado: (2022)

Pharmacogenetic information in Swiss drug labels – a systematic analysis
por: Jeiziner, C., et al.
Publicado: (2020)

Pharmacogenetic-Guided Antidepressant Selection as an Opportunity for Interprofessional Collaboration: A Case Report
por: Stäuble, Céline K., et al.
Publicado: (2021)

Pharmacogenetic Analysis Enables Optimization of Pain Therapy: A Case Report of Ineffective Oxycodone Therapy
por: Wiss, Florine M., et al.
Publicado: (2023)

Case report: Non-response to fluoxetine in a homozygous 5-HTTLPR S-allele carrier of the serotonin transporter gene
por: Stäuble, Céline K., et al.
Publicado: (2022)

Pharmacogenetic Sex-Specific Effects of Methotrexate Response in Patients with Rheumatoid Arthritis
por: Ceballos, Francisco C., et al.
Publicado: (2023)

Pharmacogenetic Analysis of Voriconazole Treatment in Children
por: Tilen, Romy, et al.
Publicado: (2022)

Severe Adverse Drug Reactions to Quetiapine in Two Patients Carrying CYP2D6*4 Variants: A Case Report
por: Stäuble, Céline K., et al.
Publicado: (2021)

Gene Polymorphisms and Pharmacogenetics in Rheumatoid Arthritis
por: Rego-Pérez, Ignacio, et al.
Publicado: (2008)

Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma
por: Hegyi, Marta, et al.
Publicado: (2016)

Development of the Swiss Database for dosing medicinal products in pediatrics
por: Tilen, Romy, et al.
Publicado: (2021)

Effects of low-dose tacrolimus therapy in combination with methotrexate in patients with methotrexate-refractory rheumatoid arthritis
por: Isozaki, Takeo, et al.
Publicado: (2010)

Nano Methotrexate versus Methotrexate in Targeting Rheumatoid Arthritis
por: Salem, Heba F., et al.
Publicado: (2022)

Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group
por: Fleischmann, R, et al.
Publicado: (2016)

Patient views on an electronic dispensing device for prepackaged polypharmacy: a qualitative assessment in an ambulatory setting
por: Allemann, Samuel S, et al.
Publicado: (2015)

PReS-FINAL-2165: Pharmacogenetic determinants of response to methotrexate in juvenile idiopathic arthritis
por: Pastore, S, et al.
Publicado: (2013)

Risk of higher dose methotrexate for renal impairment in patients with rheumatoid arthritis
por: Hayashi, Keigo, et al.
Publicado: (2020)

The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis
por: Chen, Fangfang, et al.
Publicado: (2023)

Methotrexate alone and methotrexate combined with etanercept in treatment of rheumatoid arthritis
por: Rexhepi, Sylejman, et al.
Publicado: (2012)

Methotrexate Hepatotoxicity in Patients with Rheumatoid Arthritis
por: Sotoudehmanesh, R, et al.
Publicado: (2010)

Adherence to Methotrexate therapy in Rheumatoid Arthritis
por: Arshad, Nasim, et al.
Publicado: (2016)

Interactions among Low Dose of Methotrexate and Drugs Used in the Treatment of Rheumatoid Arthritis
por: Patanè, Marinella, et al.
Publicado: (2013)

Correction to: The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis
por: Chen, Fangfang, et al.
Publicado: (2023)

Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
por: Bulatović Ćalasan, Maja, et al.
Publicado: (2013)

Comprehensive analysis of treatment response phenotypes in rheumatoid arthritis for pharmacogenetic studies
por: Standish, Kristopher A., et al.
Publicado: (2017)

Effect of Missed Doses on the Therapeutic Effect of Methotrexate for Rheumatoid Arthritis: A Pharmacokinetic Modeling Study
por: Morrison, Alan, et al.
Publicado: (2021)

Various effects of repeated rifampin dosing on coproporphyrin levels in humans
por: Kinzi, Jonny, et al.
Publicado: (2023)

Recommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis
por: Bello, Alfonso E, et al.
Publicado: (2017)

Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics
por: Conti, Valeria, et al.
Publicado: (2020)

Systematic Review of Pharmacogenetic Factors That Influence High-Dose Methotrexate Pharmacokinetics in Pediatric Malignancies
por: Taylor, Zachary L., et al.
Publicado: (2021)

Efficacy and safety of low-dose tacrolimus for active rheumatoid arthritis with an inadequate response to methotrexate
por: Lee, Won-Seok, et al.
Publicado: (2016)

Toward pharmacogenetic SLCO1B1‐guided dosing of methotrexate in arthritis using a murine Slco1b2 knockout model
por: Taylor, Zachary L., et al.
Publicado: (2021)

Clinical Pharmacogenetic Models of Treatment Response to Methotrexate Monotherapy in Slovenian and Serbian Rheumatoid Arthritis Patients: Differences in Patient's Management May Preclude Generalization of the Models
por: Jenko, Barbara, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mh7hq1gj2a7l5phffdhk2iidi7